tiprankstipranks
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market
ORKA
Oruka Therapeutics
RESEARCH TOOLSreports
Want to see ORKA full AI Analyst Report?

Oruka Therapeutics (ORKA) Income Statement

799 Followers

Oruka Therapeutics Income Statement

Last quarter (Q4 2025), Oruka Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Oruka Therapeutics's net income was $-29.58M. See Oruka Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -83.00K$ -27.00K$ -114.00K$ -91.00K$ -93.00K
Operating Expenses
$ 121.97M$ 88.10M$ 9.73M$ 19.24M$ 9.67M
Depreciation and Amortization
$ 83.00K$ 27.00K$ 114.00K$ 91.00K$ 93.00K
EBITDA
$ -121.97M$ -82.23M$ -9.81M$ -19.23M$ -9.64M
Operating Income
$ -122.05M$ -88.12M$ -9.84M$ -19.34M$ -9.77M
Other Income/Expenses
$ 16.62M$ 4.40M$ -85.00K$ 13.00K$ 19.00K
Pretax Income
$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.75M
Net Income
$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.74M
Per Share Metrics
Basic EPS
$ -2.31$ -4.99$ -8.27$ -16.68$ -8.40
Diluted EPS
$ -2.31$ -4.99$ -8.27$ -16.68$ -8.40
Weighted Average Shares Outstanding
 45.61M 16.79M 14.41M 13.90M 4.71M
Weighted Average Shares Outstanding (Diluted)
 45.61M 16.79M 14.41M 13.90M 4.71M
Currency in USD

Oruka Therapeutics Earnings and Revenue History